VCA Inc. (WOOF) Reaches New 12-Month High at $73.13
Shares of VCA Inc. (NASDAQ:WOOF) hit a new 52-week high during trading on Thursday . The stock traded as high as $73.13 and last traded at $73.01, with a volume of 286,333 shares traded. The stock had previously closed at $72.59.
Several analysts recently commented on WOOF shares. Jefferies Group started coverage on VCA in a research report on Wednesday, June 8th. They set a “hold” rating for the company. Zacks Investment Research upgraded VCA from a “hold” rating to a “buy” rating and set a $80.00 price target for the company in a research report on Friday, July 29th. Finally, Stifel Nicolaus boosted their price target on VCA from $68.00 to $75.00 and gave the stock a “buy” rating in a research report on Thursday, April 28th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and a consensus target price of $71.75.
The firm has a 50-day moving average price of $68.91 and a 200-day moving average price of $61.09. The company has a market cap of $5.86 billion and a P/E ratio of 25.84.
VCA (NASDAQ:WOOF) last posted its quarterly earnings data on Wednesday, July 27th. The company reported $0.87 earnings per share for the quarter, topping analysts’ consensus estimates of $0.82 by $0.05. The company had revenue of $653.50 million for the quarter, compared to analyst estimates of $637.18 million. During the same period in the previous year, the business posted $0.70 earnings per share. The firm’s revenue was up 19.1% compared to the same quarter last year. On average, equities research analysts forecast that VCA Inc. will post $2.93 EPS for the current fiscal year.
In other VCA news, VP Neil Tauber sold 50,000 shares of the stock in a transaction that occurred on Tuesday, May 24th. The stock was sold at an average price of $64.24, for a total transaction of $3,212,000.00. Following the completion of the sale, the vice president now directly owns 174,161 shares of the company’s stock, valued at approximately $11,188,102.64. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Arthur J. Antin sold 200,000 shares of the stock in a transaction that occurred on Wednesday, May 18th. The stock was sold at an average price of $64.04, for a total value of $12,808,000.00. Following the sale, the chief operating officer now directly owns 70,870 shares of the company’s stock, valued at $4,538,514.80. The disclosure for this sale can be found here.
Several hedge funds have bought and sold shares of WOOF. US Bancorp DE boosted its stake in VCA by 16.6% in the fourth quarter. US Bancorp DE now owns 30,684 shares of the company’s stock valued at $1,687,000 after buying an additional 4,369 shares in the last quarter. Principal Financial Group Inc. boosted its stake in VCA by 2.1% in the fourth quarter. Principal Financial Group Inc. now owns 260,395 shares of the company’s stock valued at $14,322,000 after buying an additional 5,275 shares in the last quarter. BNP Paribas Arbitrage SA boosted its stake in VCA by 100.6% in the fourth quarter. BNP Paribas Arbitrage SA now owns 26,838 shares of the company’s stock valued at $1,476,000 after buying an additional 13,462 shares in the last quarter. KBC Group NV boosted its stake in VCA by 24.4% in the fourth quarter. KBC Group NV now owns 88,993 shares of the company’s stock valued at $4,895,000 after buying an additional 17,429 shares in the last quarter. Finally, Bank of Montreal Can boosted its stake in VCA by 21.1% in the fourth quarter. Bank of Montreal Can now owns 292,384 shares of the company’s stock valued at $16,081,000 after buying an additional 50,966 shares in the last quarter.
VCA Inc is an animal healthcare company. The Company operates through five segments. Its Animal Hospital segment provides veterinary services for companion animals and sells related retail and pharmaceutical products. Its Laboratory segment provides diagnostic laboratory testing services for veterinarians, both associated with its animal hospitals and those independent of the Company.
Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.